LRP-1 mediates the adverse effect of NAFLD on peripheral Aβ clearance, thereby contributing to cerebral Aβ accumulation and cognitive impairment in NAFLD. The gene discussed is LRP1; the disease is metabolic dysfunction-associated steatotic liver disease.